Skip to NavigationSkip to content

News

The FDA has chosen not to approve an expanded indication of 2.5mg Jardiance (empaglifozin) as an adjunct to insulin in the treatment of type 1...
Dr Anthony Fauci, the Director of the National Institute of Allergy and Infectious Disease in the US, said that people between the ages of 20 and 44...
ViiV Healthcare has secured its first global approval for its once-monthly treatment Cabenuva, it has emerged, to replace current antiretroviral...
Researchers have used artificial intelligence to train algorithms to predict tumour sensitivity to systemic cancer therapies.
The Trump administration is not relaxing sanctions on Iran, despite the country having one of the highest death tolls from coronavirus.
Last night, Los Angeles County, and later California State, announced a mandate to make people work and stay at home unless they are vital to the...
Gilead’s Epclusa (sofosbuvir and velpatasvir) has been awarded new marketing approval from the FDA in the treatment of hepatitis C virus (HCV) in...
The COVID-19 coronavirus continues to dominate the news: A flu drug has appeared to be effective in treating COVID-19 while new research shows that...
The COVID-19 pandemic will affect European launches of drugs for a host of diseases including HIV, cancer and sickle cell disease, according to...
A new study into how the body fights influenza could help improve cancer immunotherapies.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches